XinKailian Biotechnology (Hainan) Co., Ltd. (hereinafter referred to as the Company) was registered and established in Haikou, the capital of Hainan Free Trade Port in December 2022. The office and business premises are located in the Yaogu Industrial Park in Haikou City. It is an emerging enterprise mainly engaged in biotechnology development, consulting, transfer, and modern high-tech production. The company adheres to the concept of "technology drives development, health achieves the future" and adopts a dual-core driven development model of R&D + production to provide customers with one-stop services from R&D, production to the market. The company is a key investment project of the Haikou Industrial Investment Conference in December 2023, and entered the Haikou National High-tech Zone project in the same year.
The company built a "health food R&D technology service platform and production base" at the end of 2023. The production base fully complies with the food GMP certification requirements and has completed registration with the US FDA. It is a production base for health food raw materials with completely independent intellectual property rights, complete system certification and import substitution: reduced coenzyme Q10 (ubiquinol) and its derivatives, oxidized coenzyme Q10 (ubidecarenone) raw materials. With more than 5,000 square meters of office and production space, it has introduced a number of advanced production equipment and equipped with complete high-end testing instruments. At the same time, it has built a complete organizational structure and has a complete global certification system for health foods. The certification system covers food safety management system certification (ISO2200:2018), quality management system certification (GB/T19001-2016/ISO9001:2015), hazard analysis and critical control point system certification (HACCP), occupational health and safety management system certification (GB/T45001-2020/ISO45001:2018), environmental management system certification (GB/T24001-2016/ISO14004:2015), NSF-GMP (current good manufacturing practice for human food) and HAB-Hala (global halal certification) and Kosherer (kosher certification), BPJPHHalal (Indonesian halal certification), etc. (qualification information is attached).
The company's current partners mainly include well-known foreign companies such as Japan PEA and Denmark Pharma Nord. Pharma Nord is a multinational company founded in 1981 and headquartered in Denmark. At the same time, Pharma Nord is also one of the largest and most important manufacturers of nutrient products in Europe.
The company's products are a series of raw materials for reduced coenzyme Q10 (ubiquinol), which are high-quality nutritional supplements and dietary supplements, providing innovative solutions for healthy aging in many aspects, such as mitochondrial health, cardiovascular health, cognitive ability, women's health, fertility, energy generation and overall health and vitality improvement. Reduced coenzyme Q10 (ubiquinol) is produced using advanced technology to ensure the purity and effectiveness of the product. Its raw material, oxidized coenzyme Q1 (ubidecarenone), comes from a natural fermentation process, ensuring the excellent quality of downstream products. In addition, mild reaction conditions and ultra-low temperature treatment methods are used to maintain the biological activity of reduced coenzyme Q10 (ubiquinol), enhancing the absorbability and stability of the product.
Relying on the professor team of Shanghai Jiaotong University, East China University of Science and Technology, and Hainan Medical University, after years of R&D investment, and leveraging its own advantages and technical characteristics, our company has successfully achieved mass production of reduced coenzyme Q10 (ubiquinol) with independent intellectual property rights (priority review stage), becoming the first and only mass production company in China, breaking the foreign monopoly. In September 2024, it announced the launch of its GMP-certified reduced coenzyme Q10 (ubiquinol) products at the Asian Food Exhibition in Bangkok, the API Exhibition in Milan, Italy, and the Western Food Exhibition in the United States, and made its first public appearance at "Vitafoods Asia". The product has completely independent intellectual property rights and complete system certification, and its quality meets the USP43 standard.
The company adheres to the business philosophy of "caring for life and benefiting society", and is committed to the research and development and production of unique green health foods to protect the health of consumers.